REFERENCES
1. CARVALHO, MJ; TOWERS, MR; CASTRO, OSG Studies of medication use in
Brazilian hospitals: a literature review. Brazilian Journal of
Pharmacy , vol. 88, p. 77-82, 2007.
2. CAMARGO, STZ; MARRA, AR; SILVA, CV; CARDOSO, MF; MARTINO, MD;
CAMARGO, LF; CORREA, L. Secular trends of candidemia in a tertiary care
hospital. Am J Infect Control , v. 38, p. 546-551, Sep. 2010.
3. CHA, R.; SOBEL, J. Fluconazole for the treatment of candidiasis: 15
years experience. Expert Rev Anti Infect Ther . v. 2, p.
357-366,Jun.2004.
4. CHARLIER, E.; HART, A.; LEFORT, P.; RIBAUD, F.; DROMER, D.; DENNING,
W.; LORTHOLARY, O. Fluconazole for the management of invasive
candidiasis: where do we stand after 15 years? Journal of
Antimicrobial Chemotherapy , vol. 57, p. 384-410, 2006.
5. DEMITTO, OF; AMARAL, R.; BIASI, P.; GUILJERMETTI, E.; SVIDZINSKI, E.;
BAEZA, C. In vitro antifungal susceptibility of Candida spp. in patients
at the Regional University Hospital of Maringá-PR. Bras Patol Med
Lab , v. 48, p.315-321, 2012.
6. FONDEVILLA. AND.; DEGREES.; MOJAL, S.; PALOMAR, M.; MATAS, L.
Consumption of systemic antifungal agents among acute care hospitals in
Catalonia (Spain), 2008-2013. Expert Rev Anti Infect Ther, v. 14,
p. 137-144, 2016.
7. GIACOMAZZI, J.; BAETHGEN, L.; CARNEIRO, L. Ç.; MILLINGTON, MA;
DENNING, WD; COLOMBO, L.THE.; PASQUALOTTO. CL The burden of serious
human fungal infections in Brazil. Mycoses , v. 59, p.145-150,
2016.
8. HIDALGO, S.R Analysis of the antimicrobial consumption profile and
correlation with bacterial resistance of some agents isolated in blood
cultures in a teaching hospital in São Paulo [thesis]. São Paulo,
Federal University of São Paulo, 2008
9. OBEROI, J.; WATTAL, C.; GOEL, N.; RAVEENDRAN, R. et al Non-albicans
Candida species in blood stream infections in a tertiary care hospital.Indian Journal of Medical Research, vol. 136, 2012.
10. PIGATTO, M.C; UCHOA, FT; COSTA, DT Pharmacokinetics of new
antifungals for systemic use used in immunocompromised patients.Revista Brasileira Farmácia , vol. 90, p.85-94, 2009.
11. MARTINEZ, ROBERTO. Update on the use of antifungal agents.Brazilian Journal of Pulmonology , vol. 32, p. 449-460, 2006.
12. LAI, CC; CHU, CC; WANG CY
Association between incidence of candidaemia and consumption of
antifungal agents at a medical center in Taiwan. Int J Antimicrob
Agents, v. 40, p.349-353, 2012.
13. NEOFYTOS, D.; BEYROUTY, C.; SIMONE, J. Pharmacobiology of
Infections . In: WALDMAN, AS; TERZIC, A. Pharmacoloy and Therapeutics:
Principles to Practice, 2008.
14. PAPPAS PG; KAUFFMAN CA; ANDES, DR et al. Clinical Practice Guideline
for the Management of Candidiasis: Update by the Infectious Diseases
Society of America. Clin Infect Dis , 2016.
15. BRAZIL. Ministry of Economics. Price Panel. Available
in:https://paineldeprecos.planejamento.gov.br/. Accessed on: 25
Nov. 2020.
17. RODRIGUES, F.; BERTOLDI. Profile of antimicrobial use in a private
hospital. Science & Collective Health. v. 15, 2010.
18. SASSO, M.; ROGER Ç.; POUJOL, H.; BARBAR S.; LEFRANT, JY; LACHAUD, L.
Changes in the distribution of colonizing and infecting Candida spp.
isolates, antifungal drug consumption and susceptibility in a French
intensive care unit: A 10-year study. Mycoses . v. 60, p. 720-780,
2017.
19. SILVA, AAF; TRAJANO, BPL; WALNUT, CN; SOUSA, S, K.; RABBIT, ML;
NUNES, MCRM; Analysis of Consumption and Cost of Antifungal.
Journal of Health Sciences . HU-UFPI, v.1, Jan-Apr, 2018.
20. SALCI, P. T. Characterization
of fluconazole use in adult ICU. Dissertation (Master in Science Applied
to Pharmacy)-Department of Clinical Analysis and Biomedicine, São Paulo,
2011.
21. SIOPE, M.; TARPATZI, A.; DAMIANIDOU, S.; VASILAKOPOULOU, A.; VOURLI,
S.; POURNARAS, S.; MELETIADIS, J. Epidemiological trend of fungemia in
Greece with a focus on candidemia during the recent financial crisis: a
10-year survey in a tertiary care academic hospital and review of
literature. Antimicrobial Agents and Chemotherapy , v.
64, p. 1-17, 2020.
22. SHARIFZADEH, A.; SHOKRI, H. Oropharyngeal candidiasis and antifungal
assessment of candida glabrata in patients with HIV infection.Trakia Journal of Sciences , v.16, p.60-66, 2016.
23. VALLABHANENI S, KALLEN A, TSAY
S, et al. Investigation of the first seven reported cases of Candida
auris, the globally emerging invasive, multidrug-resistant fungus,MMWR Morb Mortal Wkly Rep . United States, August, 2016.
24. WHO. ATC/DDD Index. World Health Organization Collaborating Center
for Drug Statistics Methodology, Dec. 2020. Available
in:<https://www.whocc.no/atc_ddd_index/>
Accessed on: 08 Nov. 2020.
25. WITH DE KATJA., BAUERT, S.;
KNOTH, H.; DORJE, F. et al. Hospital use of systemic antifungal drugs.BMC Clinical Pharmacology , p.1-6, 2005.
26. ZERVOS, M.; MEUNIER, F. Fluconazole (Diflucan): a review. Int
J Antimicrob Agents,